Precision functional mapping for target engagement in drug development
- PMID: 39103494
- PMCID: PMC11525882
- DOI: 10.1038/s41386-024-01945-9
Precision functional mapping for target engagement in drug development
Erratum in
-
Correction: Neuropsychopharmacology Volume 50 Issue 1.Neuropsychopharmacology. 2025 May;50(6):1019-1020. doi: 10.1038/s41386-025-02087-2. Neuropsychopharmacology. 2025. PMID: 40108440 Free PMC article. No abstract available.
Conflict of interest statement
JSS is co-author of a provisional patent (Patent 020949/US 15060-1787) for the use of precision functional mapping for measuring target engagement by experimental therapeutics. Within the last year, JSS was an employee of Sumitomo Pharma America and received consulting fees from Longitude Capital. These potential conflicts of interest have been reviewed and are managed by Washington University School of Medicine.
References
-
- Siddiqi SH, Kandala S, Hacker CD, Bouchard H, Leuthardt EC, Corbetta M, et al. Precision functional MRI mapping reveals distinct connectivity patterns for depression associated with traumatic brain injury. Sci Transl Med. 2023;15:eabn0441. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
